Abstract
The combination of a red light PDT agent and a Pt(ii)-based chemotherapeutic drug at the molecular level maintains the intrinsic functions of each unit; the conjugated complexes exhibit remarkable photocytoxicity and demonstrate potential to serve as agents for DNA-targeting PDT as well as red light photochemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 908-910 |
| Number of pages | 3 |
| Journal | Chemical Communications |
| Issue number | 8 |
| DOIs | |
| State | Published - 2009 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Molecular combo of photodynamic therapeutic agent silicon(iv) phthalocyanine and anticancer drug cisplatin'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver